The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials (Q36611045)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 August 2007
edit
Language Label Description Also known as
English
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
scientific article published on 28 August 2007

    Statements

    The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials (English)
    S Marchetti
    J H M Schellens
    28 August 2007
    3 September 2007
    1 reference
    19 September 2019
    577-581

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit